Literature DB >> 17513757

Interaction of PRP4 with Kruppel-like factor 13 regulates CCL5 transcription.

Boli Huang1, Yong-Tae Ahn, Lisa McPherson, Carol Clayberger, Alan M Krensky.   

Abstract

Activation of resting T lymphocytes initiates differentiation into mature effector cells over 3-7 days. The chemokine CCL5 (RANTES) and its major transcriptional regulator, Krüppel-like factor 13 (KLF13), are expressed late (3-5 days) after activation in T lymphocytes. Using yeast two-hybrid screening of a human thymus cDNA library, PRP4, a serine/threonine protein kinase, was identified as a KLF13-binding protein. Specific interaction of KLF13 and PRP4 was confirmed by reciprocal coimmunoprecipitation. PRP4 is expressed in PHA-stimulated human T lymphocytes from days 1 and 7 with a peak at day 3. Using an in vitro kinase assay, it was found that PRP4 phosphorylates KLF13. Furthermore, although phosphorylation of KLF13 by PRP4 results in lower binding affinity to the A/B site of the CCL5 promoter, coexpression of PRP4 and KLF13 increases nuclear localization of KLF13 and CCL5 transcription. Finally, knock-down of PRP4 by small interfering RNA markedly decreases CCL5 expression in T lymphocytes. Thus, PRP4-mediated phosphorylation of KLF13 plays a role in the regulation of CCL5 expression in T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513757      PMCID: PMC2674583          DOI: 10.4049/jimmunol.178.11.7081

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  RANTES is a chemotactic and activating factor for human eosinophils.

Authors:  R Alam; S Stafford; P Forsythe; R Harrison; D Faubion; M A Lett-Brown; J A Grant
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

2.  Identification of a major co-receptor for primary isolates of HIV-1.

Authors:  H Deng; R Liu; W Ellmeier; S Choe; D Unutmaz; M Burkhart; P Di Marzio; S Marmon; R E Sutton; C M Hill; C B Davis; S C Peiper; T J Schall; D R Littman; N R Landau
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

3.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

4.  The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.

Authors:  H Choe; M Farzan; Y Sun; N Sullivan; B Rollins; P D Ponath; L Wu; C R Mackay; G LaRosa; W Newman; N Gerard; C Gerard; J Sodroski
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

5.  Activation of dual T cell signaling pathways by the chemokine RANTES.

Authors:  K B Bacon; B A Premack; P Gardner; T J Schall
Journal:  Science       Date:  1995-09-22       Impact factor: 47.728

6.  Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation.

Authors:  B D Ortiz; A M Krensky; P J Nelson
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

7.  A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes.

Authors:  Tania Nikolcheva; Stephane Pyronnet; Szu-yi Chou; Nahum Sonenberg; An Song; Carol Clayberger; Alan M Krensky
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

8.  The fission yeast prp4+ gene involved in pre-mRNA splicing codes for a predicted serine/threonine kinase and is essential for growth.

Authors:  S K Alahari; H Schmidt; N F Käufer
Journal:  Nucleic Acids Res       Date:  1993-08-25       Impact factor: 16.971

9.  Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis.

Authors:  D D Taub; T J Sayers; C R Carter; J R Ortaldo
Journal:  J Immunol       Date:  1995-10-15       Impact factor: 5.422

10.  Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine.

Authors:  C A Dahinden; T Geiser; T Brunner; V von Tscharner; D Caput; P Ferrara; A Minty; M Baggiolini
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  13 in total

1.  Evaluation of cancer dependence and druggability of PRP4 kinase using cellular, biochemical, and structural approaches.

Authors:  Qiang Gao; Ingrid Mechin; Nayantara Kothari; Zhuyan Guo; Gejing Deng; Kimberly Haas; Jessica McManus; Dietmar Hoffmann; Anlai Wang; Dmitri Wiederschain; Jennifer Rocnik; Werngard Czechtizky; Xin Chen; Larry McLean; Heike Arlt; David Harper; Feng Liu; Tahir Majid; Vinod Patel; Christoph Lengauer; Carlos Garcia-Echeverria; Bailin Zhang; Hong Cheng; Marion Dorsch; Shih-Min A Huang
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

Review 2.  Krüppel-like factors in mammalian stem cells and development.

Authors:  Agnieszka B Bialkowska; Vincent W Yang; Sandeep K Mallipattu
Journal:  Development       Date:  2017-03-01       Impact factor: 6.868

Review 3.  Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer.

Authors:  Ayesha Khalid; Joy Wolfram; Ilaria Ferrari; Chaofeng Mu; Junhua Mai; Zhizhou Yang; Yuliang Zhao; Mauro Ferrari; Xiaojing Ma; Haifa Shen
Journal:  Mini Rev Med Chem       Date:  2015       Impact factor: 3.862

Review 4.  Mammalian Krüppel-like factors in health and diseases.

Authors:  Beth B McConnell; Vincent W Yang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

5.  Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy.

Authors:  Brian J Henson; Samsiddhi Bhattacharjee; Dawn M O'Dee; Eleanor Feingold; Susanne M Gollin
Journal:  Genes Chromosomes Cancer       Date:  2009-07       Impact factor: 5.006

6.  Effects of high fat feeding on liver gene expression in diabetic goto-kakizaki rats.

Authors:  Richard R Almon; Debra C Dubois; Siddharth Sukumaran; Xi Wang; Bai Xue; Jing Nie; William J Jusko
Journal:  Gene Regul Syst Bio       Date:  2012-11-28

7.  Haploinsufficient tumor suppressor PRP4K is negatively regulated during epithelial-to-mesenchymal transition.

Authors:  Livia E Clarke; Allyson Cook; Sabateeshan Mathavarajah; Amit Bera; Jayme Salsman; Elias Habib; Carter Van Iderstine; Moamen Bydoun; Stephen M Lewis; Graham Dellaire
Journal:  FASEB J       Date:  2021-11       Impact factor: 5.834

8.  PRPF overexpression induces drug resistance through actin cytoskeleton rearrangement and epithelial-mesenchymal transition.

Authors:  Salman Ul Islam; Adeeb Shehzad; Jong Kyung Sonn; Young Sup Lee
Journal:  Oncotarget       Date:  2017-05-15

9.  Krüppel-like factors: Crippling and un-crippling metabolic pathways.

Authors:  Nina M Pollak; Matthew Hoffman; Ira J Goldberg; Konstantinos Drosatos
Journal:  JACC Basic Transl Sci       Date:  2018-03-01

10.  PRP4 Promotes Skin Cancer by Inhibiting Production of Melanin, Blocking Influx of Extracellular Calcium, and Remodeling Cell Actin Cytoskeleton.

Authors:  Muhammad Bilal Ahmed; Salman Ul Islam; Young Sup Lee
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.